Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurobiology of Aging

• Publication date

  2008-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.NEUROBIOLAGING.2007.03.014PMID 17433503PMCID PMC2667969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in the treatment of anxiety: Targeting glutamate

  2011cited by this paper
• Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease.

  2007cited by this paper
• Genetic Inactivation of the NMDA Receptor NR2A Subunit has Anxiolytic- and Antidepressant-Like Effects in Mice

  2006cited by this paper
• The chemical biology of clinically tolerated NMDA receptor antagonists

  2006cited by this paper
• Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type

  2005cited by this paper
• Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer's disease

  2004cited by this paper
• Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's disease

  2004cited by this paper
• Differential expression of N‐methyl‐d‐aspartate receptor NR2 isoforms in Alzheimer's disease

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia.

  2003cited by this paper
• Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease.

  2003cited by this paper
• Glutamate receptor function in learning and memory.

  2003cited by this paper
• Glutamatergic systems in Alzheimer's disease

  2003cited by this paper
• Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer’s disease

  2003cited by this paper
• Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors.

  2003cited by this paper
• Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer’s Disease

  2003cited by this paper
• N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease.

  2002cited by this paper
• Noradrenergic changes, aggressive behavior, and cognition in patients with dementia.

  2002cited by this paper
• N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease.

  2001cited by this paper
• Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease

  2001cited by this paper
• NMDA receptor regulation of memory and behavior in humans

  2001cited by this paper
• Psychosis of Alzheimer’s disease is associated with elevated muscarinic M2 binding in the cortex

  2001cited by this paper
• PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants.

  2000cited by this paper
• Orbitofrontal cortex pathology in Alzheimer's disease.

  2000cited by this paper
• Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease

  1999cited by this paper
• The glutamate receptor ion channels.

  1999cited by this paper
• Turnover Analysis of Glutamate Receptors Identifies a Rapidly Degraded Pool of the N-Methyl-d-aspartate Receptor Subunit, NR1, in Cultured Cerebellar Granule Cells*

  1999cited by this paper
• NMDA receptor hypofunction model of schizophrenia.

  1999cited by this paper
• Age-related changes in [3H]MK-801 binding in the Fischer 344 rat brain.

  1998influential reference
• NMDA receptor subunits in the postsynaptic density of rat brain: expression and phosphorylation by endogenous protein kinases.

  1998cited by this paper
• Functional expression of recombinant N-methyl-D-aspartate receptors in the yeast Saccharomyces cerevisiae--localization and pharmacological characterization.

  1998influential reference
• Glutamate in CNS disorders as a target for drug development: an update.

  1998cited by this paper
• An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease

  1997cited by this paper
• Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.

  1997cited by this paper
• Presynaptic Serotonergic Markers in Community‐Acquired Cases of Alzheimer's Disease: Correlations with Depression and Neuroleptic Medication

  1996cited by this paper
• Behavioral and Psychological Signs and Symptoms of Dementia: Implications for Research and Treatment. Proceedings of an international consensus conference. Lansdowne, Virginia, April 1996.

  1996cited by this paper
• The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region.

  1996cited by this paper
• The spectrum of behavioral changes in Alzheimer's disease

  1996cited by this paper
• Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain

  1995cited by this paper
• Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.

  1995cited by this paper
• Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.

  1995influential reference
• Alternatively spliced isoforms of the NMDARI receptor subunit.

  1995cited by this paper
• Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats.

  1995cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).

  1995cited by this paper
• Cloned glutamate receptors.

  1994cited by this paper
• The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential.

  1994cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.

  1994influential reference
• Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives

  1993cited by this paper
• Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test.

  1993cited by this paper
• Molecular diversity of the NMDA receptor channel

  1992influential reference
• Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors.

  1992cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Glycine is a coagonist at the NMDA receptor/channel complex.

  1990cited by this paper
• Reduced Glycine Stimulation of [3H]MK‐801 Binding in Alzheimer's Disease

  1989cited by this paper
• Loss of glycine-dependent radioligand binding to the N-methyl-D-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease.

  1989cited by this paper
• [3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes

  1988cited by this paper
• Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

  1984cited by this paper
• Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease.

  1983cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease

  2025cites this paper
• Non-Genetic Risk Factors of Alzheimer's Disease: An Updated Umbrella Review

  2024cites this paper
• Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases

  2024cites this paper
• Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease

  2022cites this paper
• Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline

  2022cites this paper
• Emotion Processing Dysfunction in Alzheimer’s Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology

  2022cites this paper
• Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach

  2019cites this paper
• The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia

  2019cites this paper
• The Role of miR-150 in Stress-Induced Anxiety-Like Behavior in Mice

  2018cites this paper
• Morphological and Pathological Characteristics of Brain in Diabetic Encephalopathy

  2018cites this paper
• Effets de l’administration de tétrahydrobioptérine en condition physiologique et pathologique : De la neurobiologie au comportement

  2018cites this paper
• Heterómeros de receptores de dopamina d1 y de histamina h3 como potenciales dianas terapéuticas en trastornos adictivos y enfermedades neurodegenerativas

  2018cites this paper
• Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer’s Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease

  2016cites this paper
• Effects of repetitive transcranial magnetic stimulation on synaptic plasticity and apoptosis in vascular dementia rats.

  2015cites this paper
• Differential Alterations of Neocortical GluN Receptor Subunits in Patients with Mixed Subcortical Ischemic Vascular Dementia and Alzheimer's Disease

  2015cites this paper
• Altered emotionality, hippocampus-dependent performance and expression of NMDA receptor subunit mRNAs in chronically stressed mice

  2014cites this paper
• Depression in Alzheimer's Disease: Epidemiology, Mechanisms, and Management

  2014cites this paper
• Blockade of NR 2 A-Containing NMDAReceptors Induces Tau Phosphorylation in Rat Hippocampal Slices

  2014cites this paper
• Memantine hydrochloride in the treatment of dementia subtypes.

  2013cites this paper
• Low-frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) reverses Aβ(1-42)-mediated memory deficits in rats.

  2013influential citation
• A network view on neurodegenerative disorders

  2013cites this paper
• A virtual screening procedure combining pharmacophore filtering and molecular docking with the LIE method

  2012cites this paper
• Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

  2012cites this paper
• NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer’s Disease

  2012cites this paper
• Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses

  2011cites this paper
• Fabrication and use of D-serine biosensors for characterising D-serine signalling in rat brain

  2010cites this paper
• Blockade of NR2A-Containing NMDA Receptors Induces Tau Phosphorylation in Rat Hippocampal Slices

  2010cites this paper
• Current awareness in human psychopharmacology

  2009cites this paper
• Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.

  2009cites this paper
• High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain.

  2009cites this paper
• This Work Is Licensed under a Creative Commons Attribution-noncommercial 3.0 Unported License Review Neuropathology of Depression in Alzheimer's Disease: Current Knowledge and the Potential for New Treatments

  year unknowncites this paper